Mastrapasqua Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $400K | Sell |
2,685
-70
| -3% | -$10.3K | 0.05% | 132 |
|
|
2023
Q2 | $371K | Sell |
2,755
-15
| -0.5% | -$2.2K | 0.04% | 132 |
|
|
2023
Q1 | $441K | Sell |
2,770
-123
| -4% | -$18.8K | 0.05% | 136 |
|
|
2022
Q4 | $468K | Buy |
2,893
+570
| +25% | +$87.4K | 0.06% | 134 |
|
|
2022
Q3 | $312K | Buy |
2,323
+510
| +28% | +$73.2K | 0.05% | 135 |
|
|
2022
Q2 | $278K | Buy |
1,813
+205
| +13% | +$31.3K | 0.04% | 145 |
|
|
2022
Q1 | $261K | Hold |
1,608
| – | – | 0.03% | 137 |
|
|
2021
Q4 | $218K | Buy |
+1,608
| New | +$190K | 0.02% | 133 |
|
|
2019
Q3 | – | Sell |
-11,727
| Closed | -$853K | – | 131 |
|
|
2019
Q2 | $853K | Sell |
11,727
-35
| -0.3% | -$2.75K | 0.16% | 100 |
|
|
2019
Q1 | $948K | Sell |
11,762
-82
| -0.7% | -$6.71K | 0.18% | 97 |
|
|
2018
Q4 | $1.09M | Sell |
11,844
-210
| -2% | -$18.5K | 0.24% | 89 |
|
|
2018
Q3 | $1.14M | Sell |
12,054
-95
| -0.8% | -$9.01K | 0.22% | 89 |
|
|
2018
Q2 | $1.13M | Sell |
12,149
-200
| -2% | -$19.5K | 0.22% | 89 |
|
|
2018
Q1 | $1.17M | Sell |
12,349
-265
| -2% | -$29.1K | 0.24% | 90 |
|
|
2017
Q4 | $1.22M | Buy |
12,614
+80
| +0.6% | +$7.54K | 0.25% | 86 |
|
|
2017
Q3 | $1.11M | Sell |
12,534
-221
| -2% | -$16.8K | 0.23% | 90 |
|
|
2017
Q2 | $925K | Buy |
12,755
+660
| +5% | +$44.4K | 0.2% | 93 |
|
|
2017
Q1 | $788K | Buy |
12,095
+2,427
| +25% | +$153K | 0.18% | 103 |
|
|
2016
Q4 | $605K | Buy |
9,668
+168
| +2% | +$10.3K | 0.15% | 106 |
|
|
2016
Q3 | $599K | Buy |
9,500
+595
| +7% | +$38.5K | 0.15% | 100 |
|
|
2016
Q2 | $551K | Buy |
8,905
+300
| +3% | +$18.3K | 0.14% | 111 |
|
|
2016
Q1 | $492K | Buy |
8,605
+555
| +7% | +$30.9K | 0.11% | 111 |
|
|
2015
Q4 | $477K | Sell |
8,050
-370
| -4% | -$21.3K | 0.12% | 110 |
|
|
2015
Q3 | $458K | Sell |
8,420
-140
| -2% | -$9.11K | 0.12% | 113 |
|
|
2015
Q2 | $575K | Buy |
+8,560
| New | +$559K | 0.14% | 100 |
|
|
2015
Q1 | – | Sell |
-8,345
| Closed | -$546K | – | 44 |
|
|
2014
Q4 | $546K | Buy |
+8,345
| New | +$526K | 0.13% | 104 |
|
|
2014
Q2 | $468K | Buy |
8,285
+65
| +0.8% | +$3.41K | 0.11% | 113 |
|
|
2014
Q1 | $423K | Sell |
8,220
-1,085
| -12% | -$54.8K | 0.1% | 116 |
|
|
2013
Q4 | $491K | Sell |
9,305
-105
| -1% | -$5.16K | 0.11% | 113 |
|
|
2013
Q3 | $421K | Sell |
9,410
-67,449
| -88% | -$2.99M | 0.1% | 117 |
|
|
2013
Q2 | $3.18M | Buy |
+76,859
| New | +$3.36M | 0.84% | 48 |
|
Other funds holding ABBV
Mastrapasqua Asset Management's ABBV Position: Q3 2023 in Review
Mastrapasqua Asset Management reduced its AbbVie (ABBV) stake by 2.5% in Q3 2023, selling an estimated $10.3K and leaving 2,685 shares worth $400K. The position accounts for 0.05% of the portfolio, ranked #132.
Mastrapasqua Asset Management first reported a position in ABBV in Q2 2013 and has held it in 31 quarters since. The position peaked at $3.18M in Q2 2013. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.
- Mastrapasqua Asset Management held 2,685 shares of AbbVie worth $400K as of Q3 2023.
- Mastrapasqua Asset Management sold 70 AbbVie shares in Q3 2023, an estimated $10.3K.
- AbbVie made up 0.05% of Mastrapasqua Asset Management's portfolio in Q3 2023, its #132 holding.
- Mastrapasqua Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 31 quarters since.
- Mastrapasqua Asset Management's AbbVie position peaked at $3.18M in Q2 2013.
- 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.
Based on Mastrapasqua Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.